An Open Positron Emission Tomography Study to Assess the Effects of Varying Mass of AZD4694 on Radioligand Binding Parameters in Healthy Volunteers and Patients With Alzheimer's Disease

Clinical trial NCT01325402 · COMPLETED

Trial details

NCT number

NCT01325402

Sponsor

AstraZeneca

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2011-08-01

Primary completion

2012-11-01

Enrollment

16

View on ClinicalTrials.gov